Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy

Pediatric Neurology

Volumn 16, Issue 3, 1997, Pages 201-205

  Farrell, Kevin ^a,b   Connolly, Mary B ^a   Munn, Robert ^a   Peng, Shumin ^a   MacWilliam, Laurie M ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Forest Sciences Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; LAMOTRIGINE; VALPROIC ACID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GENERALIZED EPILEPSY; HUMAN; INTRACTABLE EPILEPSY; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; SEIZURE; TREATMENT OUTCOME;

ADOLESCENT; ANTICONVULSANTS; BENZODIAZEPINES; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; EPILEPSY, GENERALIZED; FEMALE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; RETREATMENT; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 0030924957     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(97)00010-6     Document Type: Article

References (26)

1. Goa KL, Ross SR, Chrisp P. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993;46: 152-76.
2. Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of lamotrigine for refractory partial seizures. Epilepsia 1989;30:356-63.
3. Sander JWAS, Patsalos PN, Oxley JR, Hamilton MJ, Yuen WC. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 1990;6:221-6.
4. Schapel GJ, Beran RG, Vajda FJE, et al. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatry 1993;56:448-53.
5. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Out-comes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-22.
6. Brodie MJ, Richens A, Yuen AWC. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-9.
7. Binnie CD, Van Emde Boas W, Kasteleijn-Nolst Trenité DGA, et al. Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia 1986;27:248-54.
8. Timmings PL, Richens A. Lamotrigine in primary generalized epilepsy. Lancet 1992;339:1300-1.
9. Timmings PL, Richens A. Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome. Eur Neurol 1992;32:305-7.
10. Battino D, Buti D, Croci D, et al. Lamotrigine in resistant childhood epilepsy. Neuropediatrics 1993;24:332-6.
11. Gibbs J, Appleton RE, Rosenbloom L, Yuen WC. Lamotrigine for intractable childhood epilepsy: a preliminary communication. Dev Med Child Neurol 1992;34:368-71.
12. Manonmani V, Wallace SJ. Epilepsy with myoclonic absences. Arch Dis Child 1994;70:288-90.
13. Schlumberger E, Chavez F, Palacios L, Rey E, Pajot N, Dulac O. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 1994;35:359-67.
14. Besag FMC, Wallace SJ, Dulac O, Alving A, Spencer SC, Hosking G. Lamotrigine for the treatment of epilepsy in childhood. J Pediatr 1995;127:991-7.
15. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22:489-501.
16. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
17. Dulac O. The use of lamotrigine in children. Rev Contemp 1994;5:133-9.
18. Richens A, Yuen AWC. Overview of the clinical efficacy of lamotrigine. Epilepsia 1992;32(suppl 2):S13-6.
19. Yuen AWC, Rafter JEW. Lamotrigine (Lamictal) as add-on therapy in pediatric patients with treatment-resistant epilepsy: An overview. Epilepsia 1992;33(suppl 3):82-3.
20. Veggiotti P, Cieuta C, Rey E, Dulac O. Lamotrigine in infantile spasms. Lancet 1994;344:1375-6.
21. Appleton RE. Epilepsy with myoclonic absences. Arch Dis Child 1994;71:180.
22. Stewart J, Hughes E, Reynolds EH. Lamotrigine for generalized epilepsies. Lancet 1992;340:1223.
23. Richens A. Safety of lamotrigine. Epilepsia 1994;35(suppl 5): S37-40.
24. Yuen AWC, Land G, Weatherley BC, Peck AW. Sodium valproate acutely inhibits lamotrigine metabolism. Br J Clin Pharmacol 1992;33:511-3.
25. Chadwick D, Shaw MDM, Foy P, Rawlins MD, Turnbull DM. Serum anticonvulsant concentration and the risk of drug induced skin eruptions. J Neurol Neurosurg Psychiatry 1984;47:642-4.
26. Tavernor SJ, Wong ICK, Newton R, Brown SW. Rechallenge with lamotrigine after initial rash. Seizure 1995;4:67-71.